A recent study has been also demonstrated that the antinociceptive effects produced by DOR agonists in streptozotocin-induced type 1 diabetes in mice were significantly increased by its co-treatment with an HO-1 inducer compound [22]. The gene discussed is HMOX1; the disease is type 1 diabetes mellitus.